Pharmaceuticals by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 61 pharmaceuticals ranked by one-year price change, at +403%, ahead of Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%). Figures as of 18 Nov 2026, 15:00 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Erasca+403%
- Median
- +26.9%
- Combined market value
- AED 18.84T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +403% | AED 17.5B | AED 49.84 | 2.30% down | 403% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +286% | AED 33.6B | AED 353.72 | 2.66% up | 286% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +241% | AED 24.4B | AED 359.88 | 1.73% up | 241% up | ||
| 4 | VeradermicsMANE · Health Care | +233% | AED 19.7B | AED 466.73 | 1.15% up | 233% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +169% | AED 14.9B | AED 108.93 | 0.95% up | 169% up | ||
| 6 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +126% | AED 27.8B | AED 354.31 | 1.43% up | 126% up | ||
| 7 | Dianthus TherapeuticsDNTH · Health Care | +113% | AED 18.2B | AED 323.27 | 1.20% up | 113% up | ||
| 8 | TG TherapeuticsTGTX · Health Care | +107% | AED 35.2B | AED 233.10 | 1.21% up | 107% up | ||
| 9 | ViatrisVTRS · Health Care | +95.5% | AED 86.9B | AED 75.84 | 0.98% up | 96% up | ||
| 10 | Roivant SciencesROIV · Health Care | +90.3% | AED 103.8B | AED 143.33 | 0.81% up | 90% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | +88.2% | AED 16.8B | AED 153.65 | 0.49% down | 88% up | ||
| 12 | Amneal PharmaceuticalsAMRX · Health Care | +83.3% | AED 27.3B | AED 78.41 | 1.09% up | 83% up | ||
| 13 | Royalty PharmaRPRX · Health Care | +77.7% | AED 145.2B | AED 252.50 | 0.10% up | 78% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | +74.4% | AED 184.1B | AED 157.74 | 0.77% up | 74% up | ||
| 15 | GenmabGMAB · Health Care | +70.0% | AED 116.8B | AED 189.38 | 0.76% down | 70% up | ||
| 16 | Praxis Precision MedicinesPRAX · Health Care | +61.1% | AED 31.9B | AED 1,141.86 | 1.92% up | 61% up | ||
| 17 | AlkermesALKS · Health Care | +58.4% | AED 28.7B | AED 170.52 | 2.16% up | 58% up | ||
| 18 | Takeda PharmaceuticalTAK · Health Care | +53.6% | AED 251.7B | AED 78.78 | 0.88% down | 54% up | ||
| 19 | Merck & CoMRK · Health Care | +50.8% | AED 1.28T | AED 518.66 | 1.50% down | 51% up | ||
| 20 | Protagonist TherapeuticsPTGX · Health Care | +46.4% | AED 30.2B | AED 462.76 | 1.07% up | 46% up | ||
| 21 | Travere TherapeuticsTVTX · Health Care | +44.2% | AED 17.9B | AED 186.55 | 0.60% down | 44% up | ||
| 22 | Ligand PharmaceuticalsLGND · Health Care | +42.6% | AED 21.8B | AED 1,087.52 | 0.78% up | 43% up | ||
| 23 | Johnson & JohnsonJNJ · Health Care | +37.6% | AED 2.45T | AED 1,017.87 | 0.56% down | 38% up | ||
| 24 | Jazz PharmaceuticalsJAZZ · Health Care | +36.7% | AED 57B | AED 887.78 | 0.42% up | 37% up | ||
| 25 | Regeneron PharmaceuticalsREGN · Health Care | +36.3% | AED 365.1B | AED 3,529.24 | 0.33% up | 36% up | ||
| 26 | Eli LillyLLY · Health Care | +34.9% | AED 4.6T | AED 5,167.69 | 0.60% down | 35% up | ||
| 27 | Bristol-Myers SquibbBMY · Health Care | +34.0% | AED 454.5B | AED 222.35 | 1.32% down | 34% up | ||
| 28 | Belite BioBLTE · Health Care | +31.0% | AED 23.7B | AED 583.57 | 0.74% up | 31% up | ||
| 29 | Mirum PharmaceuticalsMIRM · Health Care | +30.5% | AED 22.1B | AED 338.37 | 0.20% up | 31% up | ||
| 30 | Ascendis PharmaASND · Health Care | +27.8% | AED 64.8B | AED 988.49 | 0.75% down | 28% up | ||
| 31 | Vertex PharmaceuticalsVRTX · Health Care | +26.9% | AED 502B | AED 1,979.79 | 0.91% up | 27% up | ||
| 32 | AbbVieABBV · Health Care | +25.7% | AED 1.89T | AED 1,066.53 | 0.83% down | 26% up | ||
| 33 | NovartisNVS · Health Care | +25.0% | AED 1.1T | AED 580.14 | 0.74% down | 25% up | ||
| 34 | United TherapeuticsUTHR · Health Care | +22.6% | AED 91B | AED 2,136.34 | 0.41% down | 23% up | ||
| 35 | Elanco Animal HealthELAN · Health Care | +20.5% | AED 48.3B | AED 96.70 | 1.86% up | 20% up | ||
| 36 | BridgeBio PharmaBBIO · Health Care | +17.2% | AED 55.3B | AED 283.83 | 0.63% up | 17% up | ||
| 37 | BeOne MedicinesONC · Health Care | +16.8% | AED 171B | AED 1,497.40 | 1.34% down | 17% up | ||
| 38 | PfizerPFE · Health Care | +14.4% | AED 591.7B | AED 103.81 | 0.72% down | 14% up | ||
| 39 | Rhythm PharmaceuticalsRYTM · Health Care | +13.0% | AED 29.7B | AED 429.01 | 0.17% up | 13% up | ||
| 40 | BioMarin PharmaceuticalBMRN · Health Care | +11.3% | AED 41.9B | AED 216.14 | 0.58% up | 11% up | ||
| 41 | Arrowhead PharmaceuticalsARWR · Health Care | +10.3% | AED 22.6B | AED 160.07 | 1.38% up | 10% up | ||
| 42 | GSKGSK · Health Care | +6.26% | AED 361.9B | AED 180.55 | 0.16% down | 6% up | ||
| 43 | Dr. Reddy's LaboratoriesRDY · Health Care | +5.27% | AED 45.9B | AED 55.05 | 1.28% up | 5% up | ||
| 44 | AstraZenecaAZN · Health Care | +2.41% | AED 1.03T | AED 661.97 | 1.11% down | 2% up | ||
| 45 | GrifolsGRFS · Health Care | +1.41% | AED 21.5B | AED 31.59 | 0.35% down | 1% up | ||
| 46 | SanofiSNY · Health Care | -4.08% | AED 418.8B | AED 174.42 | 0.08% down | 4% down | ||
| 47 | Axsome TherapeuticsAXSM · Health Care | -7.37% | AED 26.2B | AED 497.58 | 0.35% down | 7% down | ||
| 48 | Corcept TherapeuticsCORT · Health Care | -7.92% | AED 28.2B | AED 257.27 | 0.03% down | 8% down | ||
| 49 | Novo NordiskNVO · Health Care | -16.9% | AED 651B | AED 147.72 | 1.18% down | 17% down | ||
| 50 | Abbott LaboratoriesABT · Health Care | -17.0% | AED 668.3B | AED 385.87 | 0.34% up | 17% down | ||
| 51 | PTC TherapeuticsPTCT · Health Care | -20.2% | AED 18.6B | AED 222.38 | 0.31% up | 20% down | ||
| 52 | CytokineticsCYTK · Health Care | -20.3% | AED 26.8B | AED 192.54 | 1.50% up | 20% down | ||
| 53 | Cogent BiosciencesCOGT · Health Care | -20.3% | AED 18.1B | AED 104.23 | 1.90% up | 20% down | ||
| 54 | Madrigal PharmaceuticalsMDGL · Health Care | -24.0% | AED 36B | AED 1,549.90 | 0.00% up | 24% down | ||
| 55 | ABIVAXABVX · Health Care | -27.3% | AED 27B | AED 308.87 | 2.44% up | 27% down | ||
| 56 | ZoetisZTS · Health Care | -28.7% | AED 125.4B | AED 308.75 | 0.70% up | 29% down | ||
| 57 | Summit TherapeuticsSMMT · Health Care | -35.6% | AED 32.8B | AED 40.99 | 4.59% up | 36% down | ||
| 58 | InsmedINSM · Health Care | -40.1% | AED 97.9B | AED 446.12 | 0.32% down | 40% down | ||
| 59 | Legend BiotechLEGN · Health Care | -42.5% | AED 11.7B | AED 60.47 | 2.20% up | 42% down | ||
| 60 | Ionis PharmaceuticalsIONS · Health Care | -63.6% | AED 16.8B | AED 100.87 | 1.87% up | 64% down | ||
| 61 | Alnylam PharmaceuticalsALNY · Health Care | -66.0% | AED 77.1B | AED 575.29 | 0.09% up | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6727 AED).
Questions and answers
Which pharmaceuticals rank first by one-year price change?
Erasca (+403%), Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%) are the top three of the 61 pharmaceuticals ranked by one-year price change as of 18 Nov 2026, 15:00 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by one-year price change.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by one-year price change have a combined market value of AED 18.84T as of 18 Nov 2026, 15:00 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceuticals by one-year price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.